Changes in Bone Turnover and Bone Loss in HIV-Infected Patients Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine

BACKGROUND: Those receiving tenofovir/emtricitabine (TDF-FTC) had greater bone loss compared with abacavir/lamivudine (ABC-3TC) in a randomized simplification trial (STEAL study). Previous studies associated increased bone turnover and bone loss with initiation of antiretroviral treatment, however i...

Descripción completa

Detalles Bibliográficos
Autores principales: Haskelberg, Hila, Hoy, Jennifer F., Amin, Janaki, Ebeling, Peter R., Emery, Sean, Carr, Andrew, STEAL Study Group
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376146/
https://www.ncbi.nlm.nih.gov/pubmed/22719882
http://dx.doi.org/10.1371/journal.pone.0038377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376146/
https://www.ncbi.nlm.nih.gov/pubmed/22719882
http://dx.doi.org/10.1371/journal.pone.0038377

Ejemplares similares